Articles with "hospitalization heart" as a keyword



Photo from wikipedia

Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT

Sign Up to like & get
recommendations!
Published in 2020 at "ESC Heart Failure"

DOI: 10.1002/ehf2.12966

Abstract: The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). read more here.

Keywords: heart; pulmonary hospitalization; implication pulmonary; hospitalization heart ... See more keywords
Photo from wikipedia

Life Course Socioeconomic Status and Risk of Hospitalization for Heart Failure or Atrial Fibrillation in The Moli-Sani Study Cohort.

Sign Up to like & get
recommendations!
Published in 2021 at "American journal of epidemiology"

DOI: 10.1093/aje/kwab046

Abstract: We investigated the association of cumulative socioeconomic disadvantage (CSD) and socioeconomic (SES) trajectories across life course with the risk of first hospitalization for heart failure (HF) or atrial fibrillation (AF) and tested some biological mechanisms… read more here.

Keywords: hospitalization heart; life course; risk;
Photo by freestocks from unsplash

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

Sign Up to like & get
recommendations!
Published in 2019 at "Circulation"

DOI: 10.1161/circulationaha.118.038010

Abstract: Background: Subclinical inflammation is associated with an increased risk of heart failure and with adverse prognosis in patients with established heart failure. Yet, treatments specifically directed at reducing inflammation in patients with heart failure have… read more here.

Keywords: hospitalization heart; canakinumab; composite hhf; heart ... See more keywords
Photo from wikipedia

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS

Sign Up to like & get
recommendations!
Published in 2019 at "Cardiovascular Diabetology"

DOI: 10.1186/s12933-019-0921-2

Abstract: BackgroundTo examine the effects of the DPP-4i sitagliptin on CV outcomes during and after incident MI in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).MethodsTECOS randomized 14,671 participants with type 2 diabetes and atherosclerotic cardiovascular… read more here.

Keywords: sitagliptin; hospitalization heart; group; heart failure ... See more keywords
Photo from wikipedia

Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study

Sign Up to like & get
recommendations!
Published in 2021 at "Cardiovascular Diabetology"

DOI: 10.1186/s12933-020-01199-x

Abstract: Background Patients with diabetes and acute coronary syndrome (ACS) are at high risk for subsequent heart failure. Apabetalone is a selective inhibitor of bromodomain and extra-terminal (BET) proteins, epigenetic regulators of gene expression. Preclinical data… read more here.

Keywords: hospitalization heart; heart; apabetalone; heart failure ... See more keywords